TY - JOUR
T1 - Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics
AU - Waldman, S. A.
AU - Terzic, A.
N1 - Funding Information:
S.A.W. is the Samuel M.V. Hamilton Endowed Professor of Thomas Jefferson University. A.T. is Michael S. and Mary Sue Shannon Family Director, Center for Regenerative Medicine, and Marriott Family Professor of Cardiovascular Research at Mayo Clinic. This work was supported by grants from the National Institutes of Health (NIH) (R01 CA204881, R01 CA206026, P30 CA56036), Targeted Diagnostic & Therapeutics, Inc., and Mayo Clinic.
Publisher Copyright:
© 2017 ASCPT
PY - 2017/9
Y1 - 2017/9
N2 - Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery–development–regulatory–utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.
AB - Clinical Pharmacology & Therapeutics (CPT) is an established voice of the discipline, a trusted source of new knowledge showcasing discovery, translation, and application of novel therapeutic paradigms to advance the management of patients and populations. Identifying, evaluating, prioritizing, and disseminating the best science along the discovery–development–regulatory–utilization continuum are responsibilities shared through peer review. To enhance the uniformity of this essential component of quality assurance and innovation, and maximize the value of the journal and its contents to authors, reviewers, and the readership, we review key concepts concerning peer review as it specifically relates to CPT.
UR - http://www.scopus.com/inward/record.url?scp=85026847109&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026847109&partnerID=8YFLogxK
U2 - 10.1002/cpt.763
DO - 10.1002/cpt.763
M3 - Editorial
C2 - 28782825
AN - SCOPUS:85026847109
SN - 0009-9236
VL - 102
SP - 373
EP - 377
JO - Clinical pharmacology and therapeutics
JF - Clinical pharmacology and therapeutics
IS - 3
ER -